Phase 1 Study Assessing the Steady-State Concentration of Ceftazidime and Avibactam in Plasma and Epithelial Lining Fluid Following Two Dosing Regimens.
Avibactam Reverts the Ceftazidime MIC90 of European Gram-Negative Bacterial Clinical Isolates to the Epidemiological Cut-Off Value
In Vitro Activity of Aztreonam-Avibactam Against Enterobacteriaceae and Pseudomonas aeruginosa Isolated by Clinical Laboratories in 40 Countries From 2012 to 2015.
Avibactam/ceftazidime
Ceftazidime-Avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 Randomized Trial Program.
Ceftazidime Avibactam